SY

Sheikh Younis Parveiz

Active Director Director DIN 09111783
DIN 09111783 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sheikh Younis Parveiz

Data last updated:

Sheikh Younis Parveiz is a Director at Macnis Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Macnis Pharmaceuticals Private Limited reported revenue of ₹30.6 Lakh (FY 2023).

DIN 09111783
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2021
Oldest Company Age 5 yrs
Largest company Macnis Pharmaceuticals Private Limited · ₹30.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 20212021₹30.6 Lakh (FY 2023)Active

Board colleagues of Sheikh Younis Parveiz

NameDINCompanyDesignation
Abdul Ahad Shah09111772Macnis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Macnis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sheikh Younis Parveiz

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheikh Younis Parveiz

Sheikh Younis Parveiz currently holds 1 directorship: Macnis Pharmaceuticals Private Limited (Director, since 18 Mar 2021, revenue ₹30.6 Lakh (FY 2023)).

Sheikh Younis Parveiz was first appointed on 18 Mar 2021 as Director at Macnis Pharmaceuticals Private Limited.

The current boards of Sheikh Younis Parveiz's companies include Abdul Ahad Shah (Macnis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available